Real-World Performance Of Alzheimer's Drug Matches Trial Data, Study Finds
TUESDAY, Aug. 11, 2026— Sally Osmer jumped at the chance to be treated with the cutting-edge Alzheimer’s drug lecanemab.Osmer has a family history of the disease, and was diagnosed with early-stage Alzheimer’s at age 74. She didn’t notice any...
Read more »